Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy.

RA Reisfeld, BM Mueller, R Handgretinger, AliceLin-Tsing Yu, SD Gillies

Research output: Contribution to journal › Journal Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{ff0ba0bf23984f5c9300e2a5df41696a,

title = "Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy.",

author = "RA Reisfeld and BM Mueller and R Handgretinger and AliceLin-Tsing Yu and SD Gillies",

year = "1994",

language = "American English",

volume = "101",

pages = "201--212",

journal = "Progress in Brain Research",

issn = "0079-6123",

publisher = "Elsevier B.V.",

}